Stephen Juvet
Overview
Explore the profile of Stephen Juvet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bell P, Kiernan J, Ramendra R, Wang S, Huszti E, DOvidio F, et al.
J Heart Lung Transplant
. 2025 Mar;
PMID: 40081629
Background: Despite evidence that gastroesophageal reflux (GER) is harmful to the lung allograft, the mechanism of injury remains incompletely defined. We hypothesized that GER induces a humoral alloimmune response and...
2.
Vosoughi D, Ulahannan A, Li Q, Huszti E, Chruscinski A, Birriel D, et al.
J Heart Lung Transplant
. 2025 Feb;
PMID: 39971216
Background: Autoantibodies and de novo donor HLA-specific antibodies (dnDSA) may contribute to chronic lung allograft dysfunction (CLAD). However, the breadth of reactivities against self-antigens and their association with CLAD has...
3.
4.
Levy L, Moshkelgosha S, Huszti E, Wang S, Hunter S, Zhang C, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39571635
Background: Surveillance bronchoscopies with bronchoalveolar lavage (BAL) and transbronchial biopsies (TBB) are primarily used to detect acute cellular rejection (ACR) or infection in lung transplant (LTx) recipients. We previously identified...
5.
Renaud-Picard B, Moshkelgosha S, Berra G, Cheung M, Hwang D, Hedley D, et al.
J Heart Lung Transplant
. 2024 Oct;
44(1):118-124.
PMID: 39368678
Long-term survival after lung transplantation remains limited by chronic lung allograft dysfunction (CLAD), with 2 main phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). We aimed to assess...
6.
Duong A, Juvet S, Martinu T
Am J Respir Cell Mol Biol
. 2024 Sep;
71(5):622-623.
PMID: 39226579
No abstract available.
7.
Miyamoto E, Vosoughi D, Wang J, Al-Refaee J, Berra G, Daigneault T, et al.
J Heart Lung Transplant
. 2024 Aug;
44(1):105-117.
PMID: 39097215
Background: Donor human leukocyte antigen (HLA)-specific antibodies (DSA) and non-HLA antibodies can cause allograft injury, possibly leading to chronic lung allograft dysfunction (CLAD) after lung transplantation. It remains unclear whether...
8.
A Rapid Human Lung Tissue Dissociation Protocol Maximizing Cell Yield and Minimizing Cellular Stress
Duong A, Wong A, Ramendra R, Sebben D, Moshkelgosha S, MacParland S, et al.
Am J Respir Cell Mol Biol
. 2024 Jul;
71(5):509-518.
PMID: 38959415
The human lung is a complex organ that comprises diverse populations of epithelial, mesenchymal, vascular, and immune cells, which gains even greater complexity during disease states. To effectively study the...
9.
Beber S, Moshkelgosha S, White M, Zehong G, Cheung M, Hedley D, et al.
J Heart Lung Transplant
. 2024 Jun;
43(10):1654-1664.
PMID: 38852935
Background: T cells drive acute cellular rejection (ACR) and its progression to chronic lung allograft dysfunction (CLAD) following lung transplantation. International Society for Heart and Lung Transplantation grade A1 ACR...
10.
Nykanen A, Mariscal A, Duong A, Ali A, Takahagi A, Bai X, et al.
Cells
. 2024 May;
13(10.
PMID: 38786082
Lung transplantation results are compromised by ischemia-reperfusion injury and alloimmune responses. Ex vivo lung perfusion (EVLP) is used to assess marginal donor lungs before transplantation but is also an excellent...